A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients

Purpose

To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.

Condition

  • Lung Cancer

Eligibility

Eligible Ages
Between 50 Years and 77 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Eligible patients will: - Meet the Medicare criteria for lung cancer screening, as updated in February 2022: - Age 50 - 77 years - Smoked at least 20 pack years - Current smoker or quit smoking within the past 15 years - Be established with a primary care provider within the Atrium Health Wake Forest Baptist health network (defined as having completed at least 1 primary care appointment in the past 6 months or have completed at least 2 primary care appointments within the past 18 months or being scheduled to see a health network primary care provider within the next 30 days). - Have a patient portal account or cellphone number listed in the electronic health record - Have a North Carolina address listed in the electronic health record

Exclusion Criteria

The following patients will be excluded: - Patients flagged as needing a language interpreter in the electronic health record for any language other than Spanish (electronic messages and intervention are deliverable in English or Spanish only) - Those for whom lung cancer screening would be or may be inappropriate: electronic health record Prior history of lung cancer electronic health record Chest CT within the last 12 months electronic health record Those meeting the HEDIS COL-E measure exclusion criteria based on significant comorbidities and/or frailty.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Screening
Masking
Single (Investigator)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Arm A
Patient portal message first followed by up to 3 reminder text messages.
  • Other: Portal Message with Reminder Text Messages
    If the participant has an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial portal message, a final reminder text message a day before their scheduled appointment, and potentially an 'in progress' text message reminder if they start the mPATH-Lung program but do not complete it. If the participant does not have an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial portal message, the final reminder message 8 days after the initial message, and potentially an 'in progress' text message reminder.
Experimental
Arm B
Text message only with up to 3 reminder text messages.
  • Other: Text Message with Reminder Text Messages
    If the participant has an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial message, a final reminder text message a day before their scheduled appointment, and potentially an 'in progress' text message reminder. If the participant does not have an upcoming scheduled appointment, they will receive a reminder text message 5 days after initial message, the final reminder message 8 days after the initial message, and potentially an 'in progress' text message reminder.
Experimental
Arm C
Portal message only with no reminder messages.
  • Other: Portal message only
    Participant will only receive portal message with no reminder text messages.
Active Comparator
Usual Care Arm
Patients receive usual care.
  • Other: Usual Care
    Standard of care

Recruiting Locations

Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina 27157
Contact:
Study Coordinator, MD
704-355-2000
Aliza.randazzo@advocatehealth.org

More Details

Status
Recruiting
Sponsor
Wake Forest University Health Sciences

Study Contact

Study Coordinator
704-355-2000
Aliza.randazzo@advocatehealth.org

Detailed Description

Primary Objective: Evaluate the real-world effectiveness of mPATH-Lung in increasing lung cancer screening rates across diverse populations. Secondary Objectives - Compare the differential effectiveness of three outreach strategies for engaging participants with mPATH-Lung across vulnerable rural or ethnic/racial minority population subgroups. - Estimate the additional revenue generated by mPATH-Lung through increased screening and downstream care. - Evaluate the potential for over-screening and the impact of applying HEDIS-based exclusion criteria